[go: up one dir, main page]

SI2035385T1 - Inhibitorji akt proteinske kinaze b - Google Patents

Inhibitorji akt proteinske kinaze b

Info

Publication number
SI2035385T1
SI2035385T1 SI200730212T SI200730212T SI2035385T1 SI 2035385 T1 SI2035385 T1 SI 2035385T1 SI 200730212 T SI200730212 T SI 200730212T SI 200730212 T SI200730212 T SI 200730212T SI 2035385 T1 SI2035385 T1 SI 2035385T1
Authority
SI
Slovenia
Prior art keywords
akt
inhibitors
protein kinase
kinase
protein
Prior art date
Application number
SI200730212T
Other languages
English (en)
Inventor
Sajan Joseph
Renhua Li
Michael Ray Myers
Aktham Aburub
Jenny Pingqi Dai
Christopher Randall Schmid
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SI2035385T1 publication Critical patent/SI2035385T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/472Non-condensed isoquinolines, e.g. papaverine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
SI200730212T 2006-06-20 2007-06-12 Inhibitorji akt proteinske kinaze b SI2035385T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80526006P 2006-06-20 2006-06-20
US88576507P 2007-01-19 2007-01-19
EP07798410A EP2035385B1 (en) 2006-06-20 2007-06-12 Inhibitors of akt (protein kinase b)

Publications (1)

Publication Number Publication Date
SI2035385T1 true SI2035385T1 (sl) 2010-05-31

Family

ID=38834248

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200730212T SI2035385T1 (sl) 2006-06-20 2007-06-12 Inhibitorji akt proteinske kinaze b

Country Status (28)

Country Link
US (1) US7998977B2 (sl)
EP (1) EP2035385B1 (sl)
JP (1) JP2009541335A (sl)
KR (1) KR101067551B1 (sl)
AR (1) AR061240A1 (sl)
AT (1) ATE455102T1 (sl)
AU (1) AU2007261120A1 (sl)
BR (1) BRPI0713136A2 (sl)
CA (1) CA2652612A1 (sl)
CL (1) CL2007001752A1 (sl)
DE (1) DE602007004333D1 (sl)
DK (1) DK2035385T3 (sl)
DO (1) DOP2008000053A (sl)
EA (1) EA015712B1 (sl)
EC (1) ECSP088992A (sl)
ES (1) ES2336630T3 (sl)
HR (1) HRP20100147T1 (sl)
IL (1) IL195005A0 (sl)
MA (1) MA30757B1 (sl)
MX (1) MX2008015904A (sl)
NO (1) NO20090289L (sl)
PE (1) PE20080338A1 (sl)
PL (1) PL2035385T3 (sl)
PT (1) PT2035385E (sl)
SI (1) SI2035385T1 (sl)
TN (1) TNSN08529A1 (sl)
TW (1) TW200812970A (sl)
WO (1) WO2007149730A2 (sl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2300011A4 (en) 2008-05-27 2012-06-20 Dmi Life Sciences Inc THERAPEUTIC PROCESSES AND COMPOUNDS
JP2013537195A (ja) 2010-09-07 2013-09-30 ディエムアイ アクイジション コーポレイション 疾患の治療
EP2766029B1 (en) 2011-10-10 2020-03-25 Ampio Pharmaceuticals, Inc. Treatment of degenerative joint disease
AU2012323320B2 (en) 2011-10-10 2017-05-11 Ampio Pharmaceuticals, Inc. Implantable medical devices with increased immune tolerance, and methods for making and implanting
AU2012328605B9 (en) 2011-10-28 2017-08-03 Ampio Pharmaceuticals, Inc. Treatment of rhinitis
WO2014145729A2 (en) 2013-03-15 2014-09-18 Ampio Pharmaceuticals, Inc. Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
CN105764502A (zh) 2013-07-26 2016-07-13 现代化制药公司 改善比生群及其类似物及衍生物的治疗益处的组合方法
JP6723222B2 (ja) 2014-08-18 2020-07-15 アンピオ ファーマシューティカルズ,インコーポレイテッド 関節病態の治療
US10123997B2 (en) * 2015-06-15 2018-11-13 Yong Liao Target for treating hepatitis B virus
WO2016209969A1 (en) 2015-06-22 2016-12-29 Ampio Pharmaceuticals, Inc. Use of low molecular weight fractions of human serum albumin in treating diseases
US10722484B2 (en) 2016-03-09 2020-07-28 K-Gen, Inc. Methods of cancer treatment
JP7472391B2 (ja) * 2020-07-22 2024-04-22 南京正大天晴制薬有限公司 ジヒドロピリド[2,3-d]ピリミジノン誘導体の塩及び結晶形
CA3186565A1 (en) * 2020-07-22 2022-01-27 Lei Miao Unit dosage composition of akt inhibitor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL136458A0 (en) 2000-05-30 2001-06-14 Peptor Ltd Protein kinase inhibitors
CN1768040A (zh) 2003-03-28 2006-05-03 伊莱利利公司 作为akt(蛋白激酶b)抑制剂的异喹啉-5-磺酸酰胺
GB0317315D0 (en) 2003-07-24 2003-08-27 Astex Technology Ltd Pharmaceutical compounds
US7449477B2 (en) * 2003-11-25 2008-11-11 Eli Lilly And Company 7-phenyl-isoquinoline-5-sulfonylamino derivatives as inhibitors of akt (protein kinase B)

Also Published As

Publication number Publication date
EP2035385A2 (en) 2009-03-18
US7998977B2 (en) 2011-08-16
MX2008015904A (es) 2009-01-12
ES2336630T3 (es) 2010-04-14
DE602007004333D1 (de) 2010-03-04
PT2035385E (pt) 2010-03-01
NO20090289L (no) 2009-01-19
EA200970041A1 (ru) 2009-06-30
BRPI0713136A2 (pt) 2012-04-17
KR20090015978A (ko) 2009-02-12
DK2035385T3 (da) 2010-03-22
KR101067551B1 (ko) 2011-09-27
HRP20100147T1 (hr) 2010-04-30
WO2007149730A3 (en) 2008-04-24
US20090221633A1 (en) 2009-09-03
ATE455102T1 (de) 2010-01-15
ECSP088992A (es) 2009-01-30
PE20080338A1 (es) 2008-04-25
AU2007261120A1 (en) 2007-12-27
DOP2008000053A (es) 2009-01-15
WO2007149730A2 (en) 2007-12-27
EP2035385B1 (en) 2010-01-13
TNSN08529A1 (en) 2010-04-14
JP2009541335A (ja) 2009-11-26
TW200812970A (en) 2008-03-16
AR061240A1 (es) 2008-08-13
CL2007001752A1 (es) 2008-01-18
CA2652612A1 (en) 2007-12-27
EA015712B1 (ru) 2011-10-31
PL2035385T3 (pl) 2010-06-30
MA30757B1 (fr) 2009-10-01
IL195005A0 (en) 2009-08-03

Similar Documents

Publication Publication Date Title
IL195005A0 (en) Inhibitors of akt (protein kinase b)
HRP20181622T1 (hr) Imidazotriazini i imidazopirimidini kao inhibitori kinaze
EP2076128A4 (en) PROTEIN CHINESE INHIBITOR AND ITS USE METHOD
IL194699A0 (en) Tetrahydropteridines useful as inhibitors of protein kinases
HUS1500049I1 (hu) Protein kináz inhibitor vegyületek és készítmények
IL230972A0 (en) Compounds and preparations as protein kinase inhibitors
IL198487A0 (en) 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors
IL197724A0 (en) Compounds and compositions as protein kinase inhibitors
IL198315A0 (en) Compounds and compositions as protein kinase inhibitors
IL198398A0 (en) 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors
ZA200809873B (en) Inhibitors of c-fms kinase
WO2008036459A8 (en) Inhibitors of rho kinase
ZA200806871B (en) Dihydrodiazepines useful as inhibitors of protein kinases
IL194491A0 (en) Thiazolyldihydroindazole derivatives as protein kinase inhibitors
GB0608823D0 (en) Inhibitors of P13 kinase
ZA201008026B (en) Inhibitors of ikk-b serine-threonine protein kinase
GB0608837D0 (en) Inhibitors of MAP kinase
ZA200809545B (en) Inhibitors of Akt (protein kinase B)
ZA200810573B (en) Substituted 3-cyanopyridines as protein kinase inhibitors
IL197981A0 (en) Kinase inhibitors
ZA200902826B (en) IKK-B Serine-Threonine protein kinase inhibitors
HK1126497A (en) Inhibitors of akt (protein kinase b)
GB0621719D0 (en) Ikk- serine-threonine protein kinase inhibitors
GB0621977D0 (en) Inhibitors of IGF-1R protein kinase
GB0719877D0 (en) Inhibitors of protein kinases